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Control of calcium binding to and dissociation from cardiac troponin C (TnC) is
essential to healthy cardiac muscle contraction/relaxation. There are numerous aberrant
post-translational modifications and mutations within a plethora of contractile, and
even non-contractile, proteins that appear to imbalance this delicate relationship. The
direction and extent of the resulting change in calcium sensitivity is thought to drive
the heart toward one type of disease or another. There are a number of molecular
mechanisms that may be responsible for the altered calcium binding properties of TnC,
potentially the most significant being the ability of the regulatory domain of TnC to bind
the switch peptide region of TnI. Considering TnI is essentially tethered to TnC and
cannot diffuse away in the absence of calcium, we suggest that the apparent calcium
binding properties of TnC are highly dependent upon an “effective concentration” of
TnI available to bind TnC. Based on our previous work, TnI peptide binding studies
and the calcium binding properties of chimeric TnC-TnI fusion constructs, and building
upon the concept of effective concentration, we have developed a mathematical model
that can simulate the steady-state and kinetic calcium binding properties of a wide
assortment of disease-related and post-translational protein modifications in the isolated
troponin complex and reconstituted thin filament. We predict that several TnI and TnT
modifications do not alter any of the intrinsic calcium or TnI binding constants of TnC,
but rather alter the ability of TnC to “find” TnI in the presence of calcium. These studies
demonstrate the apparent consequences of the effective TnI concentration in modulating
the calcium binding properties of TnC.
Keywords: troponin C, troponin I, effective concentration, thin filament, mathematical model
INTRODUCTION
The Ca2+ sensitivity of cardiac muscle contraction is compromised by many genetic and acquired
cardiomyopathies (Hamdani et al., 2008; Tardiff, 2011; Liu et al., 2012a,b). This is of major
significance considering it has been suggested that any chronic change in the Ca2+ sensitivity
of cardiac muscle will eventually lead to a cardiomyopathy (Willott et al., 2010; Davis J. et al.,
2016). On the other hand, we have recently demonstrated that chronic Ca2+ sensitization via gene
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therapy does not lead to disease and can be utilized to protect
and therapeutically aid the heart in amurinemodel of myocardial
infarction (Shettigar et al., 2016). Consistent with these findings,
not all disease associated mutations that alter the Ca2+ sensitivity
of cardiac muscle have complete penetrance (Tardiff, 2011; Ploski
et al., 2016). Thus, either altering Ca2+ sensitivity does not
always lead to disease or certain alterations in Ca2+ sensitivity are
more or less easier to compensate. In any regard, with a deeper
understanding of the molecular mechanism(s) that control the
Ca2+ sensitivity of cardiac muscle, even better design strategies
can be employed to correct or compensate for aberrant Ca2+
binding to improve cardiac function and performance (Davis J.
P. et al., 2016).
Ultimately, the steady-state measurement of Ca2+ sensitivity
is dictated by an equilibrium established by the rates of Ca2+
binding and release (Davis and Tikunova, 2008; Chung et al.,
2016). Unfortunately, it is only in the most experimentally
reduced systems that Ca2+ binding to TnC can be directly
measured (i.e., isolated troponin C (TnC) and the Tn complex;
Tikunova and Davis, 2004; Davis et al., 2007; Tikunova et al.,
2010). Interestingly, the vast majority of disease-associated
mutations and even several of the phosphomimetics in TnI
and TnT do not have much of an impact on the Ca2+
binding properties of the isolated Tn complex, but do so
on the thin filament (Nixon et al., 2012; Liu et al., 2012b,
2014). As the biochemical systems build and become more
physiological, technical limitations necessitate having to follow
other experimental outputs, which are merely transformations
of the actual Ca2+ binding event (i.e., fluorescence, actomyosin
ATPase activity, motility or force; Davis et al., 2007; Tikunova
et al., 2010; Sommese et al., 2013; Meyer and Chase, 2016).
In these cases, it is difficult to discern intrinsic from extrinsic
influences on the apparent Ca2+ binding properties of TnC to
even know what to “fix” or target (Davis J. P. et al., 2016).
Considering TnC has only a single regulatory Ca2+-binding
site, it has been difficult to envision how normal or aberrant
alterations in so many proteins lead to changes in the Ca2+
sensitivity and kinetics of this single site. It is unclear whether
the aberrant Ca2+ sensitivity shift is caused by a direct change
in the intrinsic Ca2+ binding properties of TnC (as would be
assumed in a simple two-state switch-like mechanism), and/or
merely apparently shifting the Ca2+ sensitivity by altering
subsequent downstream events in how TnC interacts with, or
is influenced by, its other regulatory subunits (such as TnI and
TnT, and all their interacting proteins). Further complicating
molecular insight, the disease-associated protein modifications
can also impact the myocyte’s innate ability to tune Ca2+
sensitivity via phosphorylation, so that only under certain
conditions might the apparent Ca2+ sensitivity even appear
altered (Biesiadecki et al., 2007; Messer and Marston, 2014).
Depending on the system being studied, the apparent Ca2+
sensitivity of both the biochemical and physiological systems can
vary by over an order of magnitude (Biesiadecki et al., 2014).
We propose a large proportion of the variability in apparent
Ca2+ sensitivities in these different systems is subtly controlled
by Mg2+ competition and strongly influenced by TnI availability
to TnC.
With respect to TnI availability, there are fascinating
phenomena that occur at the boundaries of how we think
about the mechanical and chemical world. One such behavior,
effective concentration, emerges when reactants are restricted to
interact in very confined spaces, as occurs when two reactants are
physically tethered together (Van Valen et al., 2009). TnC and
TnI can be both artificially tethered in chimeras (Tiroli et al.,
2005; Pineda-Sanabria et al., 2014) and more naturally in the Tn
complex (Pineda-Sanabria et al., 2014; Davis J. P. et al., 2016).
Due to being tethered (Van Valen et al., 2009), TnC has the
potential to experience extremely high effective concentrations
of TnI to extremely low (in times when TnI mobility becomes
restricted). By comparing the Ca2+ binding properties of TnC-
TnI chimeras to that of their freed counterparts, we suggest
the tethering of TnC to TnI can explain: (1) why the Tn
complex has such high apparent Ca2+ sensitivity and slow Ca
dissociation (compared to the isolated protein) that is drastically
reduced and accelerated, respectively, when the Tn complex is
incorporated onto the thin filament; (2) why a large proportion
of Tn modifications seem to have no effect on the apparent Ca2+
binding properties of the isolated Tn complex, yet differences
emerge when placed in the context of the thin filament; (3) that
there are several different molecular mechanisms within and
outside of the Tn complex that influence the intrinsic and/or
apparent Ca2+ binding properties of TnC; and (4) at least
four states of TnC are required to simulate the apparent Ca2+
binding properties of TnC in different experimental and diseased
conditions.
METHODS
Biochemical Studies
Proteins Utilized
The TnI128−180 peptide was synthesized by The Ohio Peptide,
LLC (Powel, OH). We generated two TnC-TnI chimeras
consisting of the N-terminal domain of human cardiac TnC
(residues 1–89) with the C-terminal domain of human cardiac
TnI (residues 128–211) connected by a flexible and cleavable
linker containing a site for the Tobacco Etch Virus protease,
which contained the sequence GGAGGENLYFQG. For the
F27W chimera, the endogenous Cys residues within TnC were
converted into Ser and Phe 27 was converted to Trp, resulting
in the following protein sequence: MDDIYKAAVEQLTEEQKN
EFKAAFDIWVLGAEDGSISTKELGKVMRMLGQNPTPEELQ
EMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSGGAGGEN
LYFQGLTQKIFDLRGKFKRPTLRRVRISADAMMQALLGAR
AKESLDLRAHLKQVKKEDTEKENREVGDWRKNIDALSGM
EGRKKKFES. For the T53C-IAANS chimera, the endogenous
Cys residues within TnC were converted into Ser, Thr 53 was
converted to Cys (resulting in the following protein sequence:
MDDIYKAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELG
KVMRMLGQNPCPEELQEMIDEVDEDGSGTVDFDEFLVMM
VRSMKDDSGGAGGENLYFQGLTQKIFDLRGKFKRPTLRRV
RISADAMMQALLGARAKESLDLRAHLKQVKKEDTEKENRE
VGDWRKNIDALSGMEGRKKKFES) and labeled with IAANS
as previously described (Davis et al., 2007).
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Chimera Expression and Purification
Pet17b vectors containing the chimeras were transformed into
Rosetta 2 BL21 De3 bacteria and expressed after induction with 1
mM IPTG for 4 h. The bacteria were sonicated and the resulting
solution was centrifuged at 19,000 RPM at 4◦C for 30 min and
the supernatant was collected. Ammonium sulfate was added at
20% saturation to remove some of the contaminating proteins.
The solution was centrifuged again at 19,000 RPM at 4◦C for
30 min and the supernatant was collected. Ammonium sulfate
was then added to 60% saturation to precipitate the chimera.
The solution was centrifuged at 19,000 RPM at 4◦C for 30min
with the supernatant removed. The pellet was resuspended in
30mL Buffer A (20mM Tris, 2mM EDTA, 6M Urea, 0.5mM
DTT, at pH 8.0) and dialyzed at least four times against 1 L of the
same buffer. The solution was then loaded onto an SQ-15 column
equilibrated with buffer A. After an initial washing with Buffer A,
a gradient was applied with 0–25% of buffer B (buffer A with 1M
NaCl). Fractions were collected and then dialyzed against 4 L of
10mMMOPS, 150mM KCl, at pH 7.0 at least four times.
Steady-State Fluorescence Measurements
All steady-state fluorescence measurements were performed
using a Perkin-Elmer LS55 spectrofluorimeter at 15◦C. Trp
fluorescence was excited at 295 nm and monitored at 320 nm
as microliter amounts of CaCl2 were added to 2ml of titration
buffer (200mM MOPS; to prevent pH changes upon addition
of Ca2+; 150 mM KCl, 2mM EGTA, at pH 7.0) with constant
stirring. The [Ca2+] free was calculated using the computer
program EGCA02 developed by Robertson and Potter as
previously described (Davis et al., 2007). The Ca2+ sensitivities
were reported as a dissociation constant Kd, representing a mean
of at least three separate titrations ± S.E.M. The data were fit
with a logistic sigmoid function (mathematically equivalent to
the Hill equation). 0.5µM human cardiac TnCF27W was titrated
with Ca2+ in the absence or presence of up to 10µMTnI128−180.
The F27W chimera was also titrated with Ca2+ in the absence or
presence of 3mMMg2+.
Stopped-Flow Fluorescent Measurements
Ca2+ dissociation rates were characterized using an Applied
Photophysics model SX.20 stopped-flow instrument with a dead
time of 1.4ms at 15◦C. IAANS fluorescence was excited at
330 nm with emission monitored through a 420–470 nm band-
pass interference filter (Oriel, Stratford, CT). Data traces (an
average of at least five individual traces) were fit with a single
exponential equation to calculate the kinetic rates. The working
buffer used for the kinetic measurements was 10 mM MOPS,
150 mM KCl, at pH 7.0. Ten millimeters EGTA was utilized
to remove saturating Ca2+ from 1 µM of the human cardiac
T53C-IAANS TnC (in the absence or presence of increasing
concentrations of TnI128−180), uncleaved 0.5µM T53C-IAANS
chimera, or cleaved T53C-IAANS chimera (in the presence or
absence of increasing concentrations of TnI128−180). The chimera
was cleaved overnight at 4◦C by the addition of one part TEV
protease for every five parts of chimera in 10 mM MOPS, 150
mM KCl, at pH 7.0. Since we do not complex as much EGTA
with Ca2+ as will occur during the titration experiments, we
do not need to use as much MOPS to buffer the pH. Control
experiments confirmed that using buffer containing 200 mM
MOPS instead of 10mMMOPS did not affect the apparent rate of
Ca2+ dissociation from the Tn complex following T53C-IAANS
TnC fluorescence (data not shown).
Simulations and Estimations
Using Scilab, an open source numerical computational package,
we solved the differential equations to obtain the time-dependent
concentrations of each species given a set of rate constants
and initial concentrations (described below). For the two state
simulations, we plotted the TnC-Ca species as the fluorescent
state and for all other simulations we plotted the TnC-Ca-
TnI species as the fluorescent state. For the steady-state and
transient occupancy studies, the concentration of these species
were subsequently converted to a percentage of the total TnC
concentration and simply overlaid onto the actual experimental
data. For the Ca2+ dissociation and association rate studies,
we normalized the change in the concentration of the species
overtime and simply overlaid the simulations onto the actual
experimental data.
Estimation of the Effective Concentration of TnI in the
Troponin Complex
While the effective concentration of TnI for TnC cannot
be directly measured, estimations are possible. Based on the
structure of the Tn complex, it appears that the tether connecting
the switch peptide of TnI to the Tn complex is along residues
134–147. If we assume a 3.4 Angstrom distance (maximal
extension of the residues) and assume it to be the radius of
a sphere, we obtain a total volume of 1.25 × 10−22 m3. By
calculating the molarity of 1 TnI in this space using Avogradro’s
number we are able to estimate an effective concentration of
∼13mM. If we include more residues, 134–155, we estimate a
lower limit of ∼3mM. This is very much in line with previous
estimates of the effective concentration of a chimeric TnC-TnI
protein (Pineda-Sanabria et al., 2014).
Steady-State Ca2+ Binding
To simulate steady-state Ca2+ binding when Mg2+ was explicitly
considered, we ran initial simulations with 1µM TnC and 3 mM
MgCl2 to equilibrium. This was then followed by running a loop
where different levels of calcium from 0.0362 to 1000µM were
inputted and run to equilibrium. For the loop, each simulation
was run to a time span of at least 0.5 s for each inputted Ca2+
concentration to reach equilibrium. A resulting plot of pCa vs.
activated TnC ([TnC-Ca-TnI]) was developed.
Ca2+ Dissociation Kinetics
As with steady-state calcium binding, we initially began the
simulation with 1µM TnC and 3mM MgCl2 and initially ran a
simulation (at least 0.5 s time span) to determine the equilibrium
concentrations of species resulting from Mg2+ binding. This
was followed by inputting [Ca2+] of 200µM. After running a
simulation for at least 0.5 s, we inputted [EGTA] of 10mM and
ran a simulation. A plot of time vs. [TnC-Ca-TnI] was developed
and outputted to a file.
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Transient Occupancy Studies/Calcium Input Studies
We initially began the transient occupancy simulations with
1µM TnC, 3mM MgCl2, and 600µM EGTA. After running a
simulation to equilibration, we inputted [Ca2+] levels of 12.5,
25, 50, and 1000 into the simulation. The simulations were
normalized to the highest [Ca2+] level and a time vs. [TnC-
Ca-TnI] plot was developed. We also performed studies without
EGTA simulating the response of thin filaments to different
[Ca2+] levels: 2.5–20 µM.
RESULTS
One of the striking and consistent findings across the literature is
that the apparent Ca2+ binding properties of cardiac TnC vary
substantially when studied in different systems (ranging from
isolated TnC to muscle; Davis et al., 2007; Davis J. P. et al., 2016).
Based on data from our work over the years (performed under as
similar conditions as possible in simplified biochemical systems),
Figure 1A demonstrates that the apparent Ca2+ sensitivity of
TnC falls into three general Ca2+ sensitivity ranges. For instance,
the apparent Ca2+ sensitivity is the lowest (highest Kd) when
only the isolated TnC is investigated, intermediate when the Tn
complex is reconstituted onto the thin filament and highest in
FIGURE 1 | Comparison of apparent Ca2+ sensitivities and
dissociation kinetics of different states of TnC. Panel (A) shows the
apparent Ca2+ sensitivities ± SEM for TnC in the different biochemical
systems that were extracted from our earlier publications (Tikunova and Davis,
2004; Davis et al., 2007; Little et al., 2012a,b). Panel (B) shows the apparent
Ca2+ dissociation kinetics ± SEM for TnC in the different biochemical systems
that were extracted from the same earlier publications. The y-axis is in a log
scale making it difficult to see some of the error bars.
the isolated Tn complex or when the thin filament is bound
by rigor myosin heads either in reconstituted thin filaments or
Tn exchanged myofibrils. Similarly, the apparent rate of Ca2+
dissociation from TnC in these different systems somewhat scale
proportionately to the change in apparent affinity (Figure 1B),
giving the impression that the Kd changes are modulated
primarily by dissociation rate changes. Thus, the same single
EF-hand in the context of different systems can have drastically
different apparent Ca2+ binding properties.
One of the obvious differences between the simplest systems
is the presence or absence of TnI. It is well-documented that
the binding of the C-terminal domain of TnI to the regulatory
domain of TnC increases the apparent Ca2+ sensitivity and slows
the rate of Ca2+ dissociation from TnC (Figure 2; Davis and
Tikunova, 2008). As can be observed in Figure 2A, increasing
the concentration of TnI128−180 added to TnCF27W increases the
apparent Ca2+ sensitivity up to a limit. This limit approaches the
apparent Ca2+ sensitivity of a chimeric protein in which the first
89 N-terminal residues of TnCF27W were physically tethered by a
short peptide linker to the C-terminal domain of human cardiac
TnI (residues 128–211). Likewise, Figure 2B demonstrates that
the apparent rate of Ca2+ dissociation from TnC (T53C-IAANS)
slows with increasing concentration of TnI128−180down to a
limit. This limit too approaches the apparent Ca2+ dissociation
rate from a chimeric protein in which the first 89 N-terminal
residues of TnC (T53C-IAANS) were physically tethered by a
short peptide linker to the C-terminal domain of human cardiac
TnI (residues 128−211; Figure 2C). Strikingly, the Ca2+ binding
properties of the uncut chimeras and the two fluorescent TnCs
in the presence of saturating TnI128−180 are similar to that of the
troponin complex (compare to Figure 1). Thus, it takes over an
order of magnitude more isolated TnI128−180 to sensitize isolated
TnC to Ca2+ compared to the chimeras and troponin complex
in which TnC and TnI are physically tethered together (high
effective concentration) at a stoichiometric ratio of one to one.
Using the chimera, we can demonstrate the principle of
effective concentration in yet another way. Within the peptide
linker of the T53C-IAANS chimera we engineered a tobacco
etch virus protease (TEV) site that can be specifically cleaved
by TEV (Figure 2D). As can be observed in Figure 2D, the
TEV efficiently cleaves both chimeras resulting in two bands (a
TnI fragment and a TnC fragment). After TEV cleavage of the
chimera the rate of Ca2+ dissociation is no longer observable
(Figure 2E, black trace). Either the resulting rate is too fast
to observe or the freed T53C-IAANS TnC N-domain’s IAANS
fluorescence is no longer sensitive to changes in Ca2+. In any
regard, although we do not know whether the peptide ratios
of the free N-domain of TnC to the free C-domain of TnI are
at exactly one to one in the cleaved solution, a rate becomes
observable again once excess TnI128−180 is added back to the
mixture of the TEV cleaved chimera (Figure 2E, blue trace).
These experiments highlight and support that there appears to
be a significantly higher effective concentration of TnI within
the intact chimeras and potentially the troponin complex that
can drastically influence the behavior and apparent Ca2+ binding
properties of TnC.
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FIGURE 2 | Biochemical testing of the effective concentration of TnI. Panel (A) shows the apparent Ca2+ sensitivities of isolated TnCF27W in the absence or
presence of increasing concentrations of TnI128−180 compared to that of the F27W chimera. Panel (B) shows the apparent Ca
2+ dissociation rates from isolated TnC
T53C-IAANS in the presence of increasing concentrations of TnI128−180 compared to that of the T53C-IAANS chimera. Panel (C) shows the apparent rate of Ca
2+
dissociation from T53C-IAANS chimera. Panel (D) shows a representative SDS Page gel of: lane (1) molecular weight markers; lane (2) TEV; lane (3) uncut F27W
chimera; lane (4) TEV digested T53C-IAANS chimera; lane (5) TEV digested F27W chimera. The arrows point to the following proteins in descending order TEV, uncut
F27W chimera, TnI fragment, TnC T53C-IAANS fragment and TnC F27W fragment, respectively. The TnI fragments from the cut chimeras are of identical sequence
and size, suggesting the lowest fragments are TnC. Panel (E) shows the apparent rate of Ca2+ dissociation from the TEV protease digested T53C-IAANS chimera
before and after the addition of 30-fold excess TnI128−180.
Similar to the chimeras where TnI was artificially tethered
to TnC, the proper formation of the troponin complex also
physically tethers TnI-TnC (Figure 3). Thus, in the troponin
complex, the C-terminal domain of TnI is restricted within a
small volume of space potentially orbiting (or whipping) around
the N-terminal, regulatory domain of TnC (Figure 3A). If we
assume this volume to be defined by a sphere with a radius equal
to the length of TnI that extends from the IT arm up through
the switch peptide (also assuming this stretch of amino acids
to be linearly and maximally extended), the switch peptide of
TnI is restricted within a maximum volume of ∼1.7 × 106 Å3.
If we then place a single switch peptide into this volume we
can calculate what the “effective concentration” of this peptide
would be for a TnC that shares this volume space, ∼3000 µM.
This calculated value is similar to that estimated for another
TnC-TnI chimeric protein by NMR (Hwang et al., 2014; Pineda-
Sanabria et al., 2014). If we also assume that there are regions
of this volume that TnC does not share, then it is possible
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FIGURE 3 | Cartoon illustration of the effective concentration of TnI.
Panel (A) shows the crystal structure of the Tn complex [cyan TnI (purple
switch peptide); red TnC; and yellow TnT]. The blue shaded area represents a
hypothetical volume in which the TnI switch peptide may be found. Panel
(B) illustrates the potential structural change that occurs in TnI upon Ca2+
removal from TnC and TnI binding to actin.
to potentially trap, or at least temporarily restrict, TnI away
from TnC, drastically plummeting the effective concentration of
TnI that TnC “observes.” Such an occurrence is not difficult to
imagine when the Tn complex is docked onto the thin filament,
since the C-terminal domain of TnI can bind both TnC and actin
(Tripet et al., 1997; Figure 3B). It may be that several proteins,
TnT, Tm and myosin can influence the effective concentration
of TnI that TnC observes by influencing TnI’s ability to bind
actin rather than by directly altering TnC’s intrinsic Ca2+ binding
properties.
The question now arises as to how many states are required
to simulate, or model, the apparent Ca2+ binding properties of
TnC and what molecular mechanisms can explain the transition
between the states? Fascinatingly, a simple two-state system
seems to capture quite well both the steady-state and kinetic
properties of any one single system such as isolated TnC, the
Tn complex, reconstituted thin filament as well as rigor myosin
bound to the thin filament (Figures 4A–G). However, these
simulations assume that the intrinsic Ca2+ association rate and
dissociation rate from TnC must change in order to explain
observed differences between the systems or modifications
performed within a particular system (Figure 5A). A logical
physical implication of this assumption is that all modifications
or system changes that alter Ca2+ binding somehow directly
influence the structure of TnC’s EF-hand, Ca2+ coordination, or
how TnC directly interacts with TnI and/or TnT. In contrast,
we hypothesize that a change in the apparent Ca2+ binding
properties of TnC can occur upon a particular perturbation
without any structural change in the resulting Ca2+ bound
structure.
This is not a trivial matter consideringmuch effort is being put
into searching for the atomic molecular mechanism(s) behind
disease mutations, which are computationally forced to focus on
very specific areas of interest, such as the precise coordination
geometry of the Ca2+ ion itself (Lindert et al., 2012; Williams
et al., 2016). Thus, it is critical to understand what structure or
protein interactions are behind the apparent changes in Ca2+
binding and exchange, which may not be reflected in the Ca2+
bound structure itself. A prime example of this phenomenon
occurs when Mg2+ competitively competes for Ca2+ binding to
an EF-hand protein (Kucharski et al., 2016). Although a new
structure must occur to explain Mg2+ binding, the Ca2+ bound
structure will be the same regardless whether Mg2+ is present
or not (Figure 5B). Similar to our previous data demonstrating
the N-domain of cardiac TnC has a physiologically relevant and
competitive Mg2+ affinity (Tikunova and Davis, 2004; Liang
et al., 2008), the addition of Mg2+ to the TnCF27W chimera
desensitizes the apparent Ca2+ sensitivity of the chimera ∼2.5-
fold, leading to an apparent Mg2+ affinity of 2.1 ± 0.7 mM
(Figure 5C). Since Mg2+ must be present in order to maintain
the structural integrity of the Tn complex, we suggest Mg2+
competition should be taken into consideration when simulating
TnC. Although subtle, only the apparent Ca2+ association rate
utilized to approximate each system’s data is dependent on
whether the effects of Mg2+ competition are considered, not
the Ca2+ dissociation rate (Figure 5A). In essence, Ca2+ cannot
bind until Mg2+ dissociates and once Ca2+ binds, Ca2+ will
dissociate at its intrinsic rate. The data in Figures 4B–F can
be equally well-simulated by both a simple two state model
(ignoring competitive Mg2+ binding) or a three state model
(where TnC binds competitively Mg2+ or Ca2+; Figure 5B).
However, the “intrinsic” Ca2+ association rate for each individual
system using a simple two state model is significantly slower than
what the rate must be if Mg2+ competition is also considered
(Figure 5A). Thus, the effects of Mg2+ can be neglected, or lost,
within a model by modulating what would appear to be the
intrinsic Ca2+ association rate of the system.
Much more pronounced and generally accepted, as can be
observed in Figures 1, 2, the binding of TnI to isolated TnC
has a monumental impact on the apparent Ca2+ association
and dissociation rates from TnC (Kobayashi and Solaro, 2005;
Davis and Tikunova, 2008). Considering in this case two different
species can bind TnC (Ca2+ and TnI—ignoring Mg2+), it is
reasonable to assume that it is necessary to at least have a three
state model to predict TnC behavior in muscle. In fact, a three
state model has been utilized quite successfully to simulate the
apparent Ca2+ binding properties of cardiac myofibrils (Solzin
et al., 2007). Figure 6 demonstrates how a classical three state
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FIGURE 4 | Application of a two state model. Panel (A) shows a reaction schematic for a two state model of TnC’s Ca2+ binding. Panels (B–G) in black show the
apparent Ca2+ sensitivities or dissociation rates from previously published data (Davis et al., 2007; Liu et al., 2012b), overlaid in red with a two-state model simulation.
All measurements were made following the change in fluorescence of TnC T53C-IAANS in increasingly complex biochemical systems.
model would predict the experimental outcomes of Figures 1,
2. In a three-state model, TnC first binds Ca2+ with kinetics
that can be described simply for the isolated TnC (either
considering Mg2+ competition or not; Figure 6A). Although
we do not know how fast TnI can actually bind Ca2+ bound
TnC, FRET studies suggest that TnI dissociates from TnC at
least as fast as ∼110/s (keep in mind this rate too may be
an apparent rate rather than an intrinsic rate; Ouyang et al.,
2010). We estimated the TnI association rate based on a TnI
affinity to TnC of 1.2 µM, which is surprisingly close to the
apparent TnI128−180 affinity extracted from Figure 2B of∼3µM.
Figures 6B,C demonstrate a three state model incorporating TnI
binding to TnC can predict the apparent Ca2+ sensitivities and
Ca2+ dissociation rates of the Tn complex and thin filament
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FIGURE 5 | Role of competitive Mg2+ binding in regulating TnC’s
apparent Ca2+ sensitivity. Panel (A) shows how implicitly (Ignore Mg2+
Competition) or explicitly (Explicit Mg2+ Competition) affects the “intrinsic”
Ca2+ association rates for TnC in different biochemical systems. Panel (B)
shows a reaction schematic for a three state model that takes into account
explicit Mg2+ binding to TnC. Panel (C) shows the apparent shift in Ca2+
sensitivity of the F27W chimera in the presence (solid squares) or absence
(open squares) of 3mM Mg2+.
by solely altering the effective concentration of TnI without
having to alter any intrinsic rates of Ca2+ or TnI binding
to/dissociation from TnC. However, unlike what was observed
in Figures 2A,B, this three state model suggests that rather
than there being a limit to the Ca2+ sensitivity and Ca2+
dissociation rate as the TnI concentration is increased, the pCa50
of this model continuously increases (approaching infinity),
whereas the Ca2+ dissociation rate approaches an asymptote
of zero. Thus, a three state model that does not allow for
Ca2+ to dissociate from TnC until TnI dissociates predicts
that the apparent Ca2+ sensitivity would approach infinity and
the Ca2+ dissociation rate would approach zero as the TnI
concentration is continually increased. Clearly this is not the
case based on our peptide and chimera studies demonstrated
in Figure 2. Therefore, we suggest that in addition to TnI
dissociation, the TnC- Ca2+-TnI complex can also dissociate
by releasing Ca2+ as well (Figure 6D). Once TnC- Ca2+-TnI
is allowed to also dissociate via loss of Ca2+ as well as TnI,
as the concentration of TnI is increased, the apparent Ca2+
sensitivity and rate of Ca2+ dissociation approach that of the
apparent Ca2+ binding properties of the Tn complex (which we
earlier suggested senses a very high effective concentration of
TnI; Figures 6E,F).
Thus, we suggest at minimum a four state model of TnC
Ca2+ binding and dissociation is required to accurately predict
the Ca2+ binding properties of TnC (Figure 6D). Similar to the
three state model, we first assume the initiating event is Ca2+
binding to the isolated regulatory domain of TnC that possesses
very rapid Ca2+ association and dissociation rates as we have
previously demonstrated to approximate the steady-state and
kinetic behavior of isolated TnC. Next, TnI is allowed to bind
TnC- Ca2+, which is governed by the product of its intrinsic on
rate to TnC and the effective concentration of TnI that TnC “sees”
or “senses.” Once the TnC- Ca2+-TnI species forms, it has two
options to decay. The first pathway is via TnI dissociation, which
is common to the three state model and is given a rate of 110/s
consistent with FRET studies (Ouyang et al., 2010). The second
pathway is via Ca2+ dissociation, which we have set at the rate at
which Ca2+ has been observed to dissociate from the intact Tn
complex (∼40/s) with an intrinsic Ca2+ association rate similar
to that predicted by a two-statemodel for the isolated Tn complex
(see Figure 5A). Now we have a new state, TnC-TnI, which we
assume dissociates at least as fast as TnI can dissociate from TnC-
Ca2+-TnI complex at∼110/s.We also assume that the regulatory
TnC-TnI state cannot form in the absence of Ca2+, consistent
with experimental data (hence this reaction is not reversible).
Using our four state model and assuming a very high
effective concentration of TnI (of at least 850 µM—that could
actually be much higher based on the effective concentration
calculations and predictions), Figures 7A,B demonstrate we can
simulate the apparent Ca2+ binding properties of the isolated
Tn complex. By only lowering the effective concentration of TnI
to ∼8 µM (without any intrinsic rate alterations) our four state
model also predicts the apparent Ca2+ binding properties of
the reconstituted thin filament’s: (1) steady-state Ca2+ binding
affinity (Figure 7C); (2) Ca2+ dissociation rate (Figure 7D);
(3) Ca2+ association rates (Figure 7E); and (4) response to
artificial Ca2+ transients (Figure 7F). Currently the 8µM value
for effective TnI concentration required to simulate the entire set
of thin filament data is empirical. As the field learns more about
the intrinsic, as well as effective concentration, of TnI that actin
“sees/senses” (Figure 3B), one could begin to explicitly simulate
this important interaction with TnI too.
Now that we have demonstrated that changing only the
effective concentration of TnI connects TnC’s Ca2+ binding
properties between different systems, we were curious if this
mechanism might also be used to explain how certain disease
associated mutations alter the apparent Ca2+ sensitivity of TnC.
Excitingly, Figures 8A,B demonstrates that nearly half of all
the disease associated modifications in TnI and TnT that our
laboratory has studied at both the steady-state and kinetic level
can be approximated by only altering the effective concentration
of TnI that TnC “sees/senses.” Thus, we suggest the ability of
cardiac muscle to tune the effective concentration of TnI may
be a powerful mechanism to alter the apparent Ca2+ binding
properties of the thin filament without altering any intrinsic
Ca2+ or TnI binding properties of TnC. However, the remaining
Tn modifications we have studied require altering the intrinsic
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FIGURE 6 | Application of a three state model. Panel (A) shows a reaction schematic for a three state model for TnC activation. Panels (B,C) show plots of the
apparent Ca2+ sensitivity and dissociation kinetics derived from a three state model with increasing effective TnI concentration. Panel (D) shows the reaction
schematic for a four state model for TnC activation. Panels (E,F) show plots of the apparent Ca2+ sensitivity and dissociation kinetics derived from a four state
extended model with increasing effective TnI concentration.
properties of TnC as well, in order to simulate the Ca2+ binding
properties of the Tn complex and thin filament (manuscript
in preparation). Collecting both steady-state and kinetic data
from isolated Tn and the thin filament is essential to helping to
elucidate whether a change in Ca2+ binding properties is due to
intrinsic and/or extrinsic factors.
A major modulator of thin filament Ca2+ binding as well as
the speed of muscle mechanics is phosphorylation of cardiac TnI
at serine residues 23 and 24 (Biesiadecki et al., 2014; Janssen et al.,
2016). Both my, Dr. Biesiadecki’s and other laboratories have
independently measured the apparent Ca2+ binding properties
of the reconstituted thin filament under similar experimental
conditions using the phosphomimetic TnI in which Ser 23/24
have been mutated to Asp (Albury et al., 2012; Liu et al., 2014;
Nixon et al., 2014). Not surprisingly, both of our laboratories
obtain nearly identical apparent rates of Ca2+ dissociation from
our wild type and phosphomimetic reconstituted thin filaments,
suggesting our protein systems behave identically (Figure 9A).
However, an apparent discrepancy arose in comparing our
steady-state Ca2+ binding behavior of the thin filaments.
Figure 9B demonstrates that my laboratory’s wild type and
phosphomimetic thin filaments were both substantially more
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FIGURE 7 | Application of a four state model. Panels (A,B) in black show the apparent Ca2+ sensitivity and dissociation rates from the Tn complex as previously
published (Davis et al., 2007). Panels (C,D) in black show the apparent Ca2+ sensitivity and dissociation rates from the reconstituted thin filament as previously
published (Davis et al., 2007). Panel (E) in black shows the rates of Ca2+ association to the reconstituted thin filaments as previously published (Liu et al., 2012b).
Panel (F) (noisy colored curves) shows the response of the thin filaments to artificial Ca2+ transients as previously published (Liu et al., 2012b). For Panel (A–E), the
smooth red curves show the simulated output of the four state model. For Panel (F), all the smooth curves represent the simulated output of the four state model.
desensitized to Ca2+ compared to the results obtained from
the Biesiadecki laboratory. Unlike the kinetic measurements
where saturating Ca2+ and EGTA are used to measure
the Ca2+ dissociation rates and subtle differences in each
concentration will have no bearing on the results, the steady-
state measurements are highly dependent upon the precise
concentrations of both EGTA and Ca2+. Excitingly, using our
four state model and assuming only the concentration of EGTA
was different between the laboratories (by only 10% out of 2mM,
which can easily be accounted for via differences in pipettes,
equipment or H2O content of the EGTA powder) we are able
to reconcile our experimental findings. Once we were able to
correct for the Ca2+ buffering differences in our experimental
systems, we were able to simulate the behavior of TnI S23/24D in
both our data sets by making only a single intrinsic rate change
of accelerating the TnI dissociation from TnC of 110–460/s
(maintaining the effective concentration of TnI at 8µM similar
to the wild type condition).
Interestingly, Figures 9C,D demonstrate that unlike the
reconstituted thin filament, the apparent steady-state Ca2+
binding properties and Ca2+ dissociation rate of the isolated
Tn complex containing TnI S23/24D were nearly identical to
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FIGURE 8 | Changes in Only the Effective Concentration of TnI Predict
Ca2+ Binding Properties of Several TnI and TnT Modifications. Panel
(A) shows that the apparent Ca2+ sensitivities of several TnI and TnT
modifications fall on the four state TnC activation curve as the effective
concentration of TnI is increased. Panel (B) shows that the apparent Ca2+
dissociation rates of several TnI and TnT modifications fall on the four state
TnC activation curve as the effective concentration of TnI is increased. The
exact same effective TnI concentration was used for each specific protein
modification in each panel.
that of the wild type Tn complex. This result can be simply
modeled by again assuming the isolated troponin complex has
a very high effective TnI concentration (>1000µM in this
case). Thus, a high effective TnI concentration can overcome
the Ca2+ desensitizing effects of TnI S23/24D. On the other
hand, TnI S150D, a phosphomimetic that models AMP kinase
phosphorylation of TnI, sensitizes both the Tn complex and
thin filaments to Ca2+, as well as slows both systems’ Ca2+
dissociation rates (Figures 9C,D; Nixon et al., 2012, 2014). In
order to simulate these results we have assumed two alterations:
(1) the rate of Ca2+ dissociation from the TnC- Ca2+-TnI
complex is slowed by 40% (setting a new limiting value as the
effective TnI concentration is elevated) and (2) the effective
concentration of TnI for the reconstituted thin filament was
raised from 8 to 25µM. Thus, our model predicts that unlike
TnI S23/24D, TnI S150D increases the effective concentration of
TnI that TnC “sees” when incorporated onto the thin filament.
One possibility for this observation and a rationale for having
to increase the effective concentration of TnI for TnC on the
thin filament could be a weakened binding affinity of TnI
S150D for actin. Consistent with this prediction, Salhi et al.
has demonstrated TnI S150D has a weaker affinity for actin,
compared to TnI S23/24D, which had a similar actin affinity as
compared to wild type TnI (Salhi et al., 2016). This observation
suggests mechanisms that alter the ability of TnI to interact with
actin can have a profound effect of modulating the apparent
Ca2+ binding properties of TnC potentially through the effective
concentration of TnI that TnC “sees/senses.”
DISCUSSION
There has been great interest in developing mathematical
models that can recapitulate the electrical, Ca2+ and mechanical
responses of the heart. Although there are very good models
for elements of each of these processes, no model has been able
to unify all the essential steps of contraction/relaxation into a
cohesive predictive or diagnostic tool. We argue that one of the
problems arises in the need to oversimplify the systems, of which
Ca2+ binding to TnC is a prime example. Based on a wealth of
biochemical and physiological data it is clear that the apparent
Ca2+ binding properties of TnC can influence both the extent
and speed of cardiac muscle contraction, relaxation, and power
(McDonald and Herron, 2002; Biesiadecki et al., 2014; Davis
J. P. et al., 2016). By more fully understanding the underlying
mechanisms that control the intrinsic and apparent Ca2+ binding
properties of cardiac muscle it may be possible to engineer the
response of the thin filament to Ca2+ to eventually treat various
cardiovascular diseases, as we have been attempting to achieve
(Davis J. P. et al., 2016; Shettigar et al., 2016).
Although each individual state of TnC (isolated TnC, Tn
complex, thin filament, thin filament bound by strong cross-
bridges, myofibrils, etc.) can be simulated with a simple two
state system (see Figure 4), by no means does this suggest
Ca2+ binding to TnC in muscle is simple. We argue that TnC
transitions throughmultiple states even during a single heartbeat,
which can then influence the mechanics of that heartbeat when
the thin filament is altered naturally by phosphorylation or even
disease. Thus, we have set out to try and understand what might
be the major influences on Ca2+ binding to TnC as it transitions
from state to state. Clearly the ability of TnC to bind TnI is
one major factor that influences TnC’s Ca2+ binding properties
(Kobayashi and Solaro, 2005; Biesiadecki et al., 2014). However,
even this step in the process may be more complicated than just
understanding the affinity or intrinsic rate of TnI association and
dissociation fromTnC.We suggest there aremechanisms beyond
the overall “affinity” of TnC for TnI that can feed back on TnC
without altering any intrinsic parameters of TnC, such as the
effective concentration of TnI that TnC “sees/senses.”
The concept of effective concentration is not a new idea (Van
Valen et al., 2009), even as it applies to TnC (Hwang et al.,
2014), although we are the first to try and apply the concept
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FIGURE 9 | Using the four state model to reconcile data from different research groups and predicting the molecular mechanism for S150
phosphorylation. Panels (A,B) show the apparent Ca2+ dissociation rates and sensitivities for thin filaments containing control or S23/24D TnI, whereas panels
(C,D) show the apparent Ca2+ dissociation rates and sensitivities for the Tn complex containing control, S23/24D TnI or S150D TnI. For panels (A–D), the black
traces are real data previously published from the Davis lab (Liu et al., 2014), the blue traces are real data previously published from the Biesiadecki lab (Nixon et al.,
2014), the red traces are simulations for the Davis lab conditions, whereas the magenta traces are simulations for the Biesiadecki lab conditions.
to mathematically describing state transitions of TnC. Based
on our initial studies we speculate that nearly half of all the
disease associated modifications of Tn that we have studied can
be explained solely by altering the effective concentration of TnI
that TnC “sees.” Other Tn modifications such as TnI S23/24D
may have no effect on TnI’s effective concentration, whereas
others such as TnI S150D require modulating both intrinsic TnC
properties as well as the effective concentration of TnI (Salhi et al.,
2016). As we work through trying to model all our biochemical
data, we are finding there are many ways to alter the apparent
Ca2+ binding properties of TnC. Not all of the mechanisms are
as straightforward as simply accelerating or slowing the intrinsic
Ca2+ binding properties of TnC. In most cases, the potential
mechanism behind a Tn modification is not evident until the
protein modification is studied in multiple biochemical systems
(at minimum the troponin complex and the reconstituted thin
filament) both in the steady-state and kinetically. It is clear that
Ca2+ triggers extensive dynamic changes in Tn that can be altered
by disease associatedmutations (Kowlessur and Tobacman, 2012;
Liu et al., 2012b). As the model is developed to move from Ca2+
binding to force, we will need to also consider cooperative unit
communications (Gordon et al., 2000). As onemoves beyond this
TnC centric view, one will also need to consider tropomyosin
positions as well as TnT behavior when determining the ability
of Ca2+ to modulate myosin binding to actin (Mijailovich et al.,
2012).
We suggest the tethering of TnC to TnI and our model
can help to explain: (1) why the Tn complex has such high
apparent Ca2+ sensitivity and slow Ca2+ dissociation (compared
to the isolated protein) that is drastically reduced and accelerated
respectively, when the Tn complex is incorporated onto the
thin filament. Figure 2 clearly shows that the apparent Ca2+
sensitivity and dissociation rate of isolated TnC is modulated
by the concentration of TnI. Furthermore, at saturating
TnI concentrations, both the apparent Ca2+ sensitivity and
dissociation rate are very similar to the intact Tn complex
as well as the chimeras. Figure 3 illustrates that the proximal
confinement of TnI to TnC results in a high effective TnI
concentration in the Tn complex. Figures 6, 7 use our model to
show that at a high effective TnI concentration, we can accurately
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simulate Tn behavior and by solely lowering the effective TnI
concentration we can simulate thin filament behavior. (2) Why
a large proportion of Tn modifications seem to have no effect
on the apparent Ca2+ binding properties of the isolated Tn
complex, yet differences emerge when placed in the context
of the thin filament. Figure 8 shows that the apparent Ca2+
binding properties of several Tn modifications can be modeled
solely by changing the effective concentration of TnI on the
thin filament. Furthermore, at a saturating TnI concentration,
our model predicts for each of these Tn modifications that
the apparent Ca2+ binding properties of the Tn complex
are identical to that of the wild type Tn complex. Figure 9
shows an example of a modification that requires changing
an intrinsic rate parameter in order to model thin filament
behavior. However, raising the effective concentration of TnI
to saturating levels restores the Tn like behavior. In this case,
an accelerated TnI dissociation rate from TnC will be over-
powered by the high effective TnI concentration. (3) There are
several different molecular mechanisms within and outside of
the Tn complex that influence the intrinsic and/or apparent
Ca2+ binding properties of TnC. Our study focused on how
altering the effective concentration of TnI can regulate the
apparent Ca2+ binding properties of TnC. As pointed out
in the manuscript and our model, we do not exclude that
there are mutations/modifications in the Tn complex (or a
plethora of additional proteins) that can alter the apparent
Ca2+ binding properties of TnC though alternate mechanisms,
such as altering the intrinsic rates of Ca2+, Mg2+, and/or TnI
binding/dissociation from TnC. In fact, this is the point of a
companion paper to be published in this thematic issue by
the Biesiadecki lab (Salhi et al., 2016). Thus, all the intrinsic
binding and dissociation rates (Ca2+, Mg2+, and TnI) set by
the compilation of proteins in the thin and thick filaments,
as well as the effective concentration of TnI, work together
to set the overall Ca2+ sensitivity of TnC. (4) At least four
states of TnC are required to simulate the apparent Ca2+
binding properties of TnC in different experimental and diseased
conditions. Figures 6–9 demonstrate at minimum a four-state
model is needed to successfully simulate not only the steady-
state, but also kinetic behavior of a wide assortment of Tn
modifications.
In conclusion, we have generated a strikingly powerful
mathematical model that can simulate several different states
of TnC in the presence of different Tn modifications. We
have utilized the model to make predictions regarding protein
interactions that fall outside of direct TnC interactions, such
as TnI-actin binding (Salhi et al., 2016). Currently all that is
needed to connect and simulate our data is a four state model
to recapitulate TnC’s apparent Ca2+ binding properties as well
as evoking the concept of effective concentration. Considering
nearly all of the myofilament protein-protein interactions
that influence muscle contraction occur within confined and
restricted spaces, effective concentration concepts may need to
be invoked to simulate several other key reaction steps as well,
especially myosin with actin (Fuchs and Smith, 2001).
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